The Oligodendrocyte-Myelin glycoprotein gene (OMgp) is placed within an intron of the NF1 gene. Neuro®-bromin, the product of NF1, acts as a RasGAP and suppresses growth; inactivating mutations in NF1 lead to neuro®bromatosis type 1. We report that OMgp also has growth suppressive eects and downregulates mitogenic signaling pathways closely related to those in¯uenced by neuro®bromin. Overexpression of OMgp alters mitogenic signaling in NIH3T3 ®broblasts. Cells overexpressing OMgp grow more slowly in serum compared to controls and show a partial G 1 block upon cell cycle analysis. PDGF is the primary mitogen for ®broblasts in serum. Overexpression of OMgp alters PDGF signaling in ®broblasts which results in a block of mitogenic signaling. PDGF induced activation of c-Src is blocked, as is the induction of c-Myc and c-Fos, while tyrosine phosphorylation of the PDGFb receptor, PLCg1 and induction of c-Jun are intact. Although a number of genes embedded within other genes have been described, the biological signi®cance of this arrangement remains unknown. We demonstrate here that structurally unrelated products of two such genes may exercise closely related functions. Our data also raise the possibility of a role for OMgp in disorders of cell proliferation such as NF1.
Introduction
Mitogenic signaling in ®broblasts is believed to be mediated primarily through activation of receptor tyrosine kinases. PDGF is considered to be the primary mitogen in serum (Scher et al., 1979) . The engagement of the PDGF receptor by its ligand results in receptor dimerization, activation of the intrinsic tyrosine kinase function of the receptor and autophosphorylation (reviewed in Cooper and Kazlauskas, 1993; ClaessonWelsh, 1994) . Subsequently a number of substrate molecules bind to the activated receptor via their SH2 or PTB (PTyr-binding) domains and may themselves become activated through tyrosine phosphorylation (Pawson, 1995) . This leads to a cascade of signaling events causing changes in the phenotype of the cells (Schlessinger and Ullrich, 1992) . Mitogenic signaling is mediated through the Ras ± Raf ± MEK ± ERK pathway (Marshall, 1994) . Activation of MAPK (ERKs) leads to the transcription of genes which presumably mediate the mitogenic response (Hill and Treisman, 1995) . These include the immediate early genes, c-fos, c-myc and c-jun (Greenberg and Zi, 1984) .
The Src family of protein tyrosine kinases is also implicated in PDGF induced mitogenesis in ®broblasts (Erpel and Courtneidge, 1995) . The engaged PDGF receptor binds Src family members and this results in their activation (Kypta et al., 1990) . Microinjection studies using dominant negative mutants or speci®c antibodies have demonstrated that Src family members are required for PDGF induced mitogenesis in ®broblasts (Twamley-Stein et al., 1993) . Oncogenic transformation by v-src is blocked with a dominant negative Ras mutant and by Ras speci®c antibodies and is reversed by overexpression of p120 GAP, suggesting that Src works upstream of Ras (Smith et al., 1986; Feig and Cooper, 1988; DeClue et al., 1991) . Recent data, however, suggests that a Ras independent Src pathway may mediate Myc induction in response to PDGF (Barone and Courtneidge, 1995) . Down regulation of the Ras signaling cascade is mediated through the GTPase activating proteins (GAPs) which accelerate the intrinsic GTPase activity of p21 ras and in that favor the inactive GDP bound state (Boguski and McCormick, 1993) . Downregulation may also be mediated through protein phosphatases which could act at several levels (Hunter, 1995) .
Loss of function mutations in the NF1 gene (McCormick, 1995; Gutmann and Collins, 1993) are believed to cause the disordered growth and tumors characteristic of neuro®bromatosis type 1, which has a predilection for tissues derived from neural crest (Riccardi, 1981 (Riccardi, , 1992 . Neuro®bromin, the product of NF1, functions as a GAP (Xu et al., 1990) and this is thought to be the basis for its activity as a tumor suppressor, although it may also serve as a downstream eector of p21 ras (Bollag and McCormick, 1992) . Overexpression of neuro®bromin in NIH3T3 fibroblasts is growth inhibitory (Johnson et al., 1994) . Overexpression of p120 GAP inhibits and reverses oncogenic transformation of ®broblasts (DeClue et al., 1991) and blocks TPA induced activation of ERK-2, cFos expression and DNA synthesis (Nori et al., 1992) . These eects are similar to those of a dominant inhibitory c-H-ras mutant in ®broblasts which impairs mitogenic signaling by growth factors and inhibits c-Fos induction. It should be noted that in NIH3T3 ®broblasts PDGF induced c-Fos induction and mitogenesis have been shown to be Ras-dependent (Feig and Cooper, 1988; Mulcahy et al., 1985; Cai et al., 1990) .
The Oligodendrocyte-Myelin glycoprotein (OMgp) gene is one of three known genes within an intron of the neuro®bromatosis type 1 gene and on the opposite strand, the other two being Evi-2A and Evi-2B (Viskochil et al., 1991) . OMgp is a GPI linked protein which was discovered as the major peanut agglutinin binding polypeptide in the white matter of adult human central nervous system (Mikol and Stefansson, 1988) . It is a heavily glycosylated 120 kDa protein, initially, described as oligodendrocyte/myelin speci®c. Subsequent studies of the mouse central nervous system using in situ hybridization and immunohistochemistry have revealed that in addition to white matter, there is expression of OMgp in groups of neurons, including pyramidal cells of the hippocampus, Purkinje cells of the cerebellum, as well as groups of neurons in the neocortex, hypothalamus, and brain stem nuclei (Habib et al., submitted) . This distribution is similar to that of neuro®bromin (Daston et al., 1992) . The primary structure of OMgp can be divided into four distinct domains (Mikol et al., 1990) : at the amino terminus there is a 32 residue cysteine rich region, followed by 7 leucine rich repeats. Next are 4 repeats of 40 residues, rich in serines and threonines. The COOH terminus contains a hydrophobic segment probably cleaved upon attachment of a phosphatidylinositol glycan with which the protein is anchored to the plasma membrane.
In this study, we report that overexpression of the OMgp gene has potent growth suppressive eects in NIH3T3 ®broblasts similar to those seen with neuro®bromin overexpression (Johnson et al., 1994) , and that these eects result from a downregulation of mitogenic signaling pathways closely related to those in¯uenced by neuro®bromin.
Results

Transfection and eects on neuro®bromin levels
An OMgp construct was cloned into the PcDNA1/Neo vector in both a sense and an antisense orientation. NIH3T3 ®broblasts were transfected and following selection with G418, four independent clones overexpressing OMgp were identi®ed by Northern and Western blotting and used in the experiments described (clones CC, EC, LC and ZZ). We used antisense clones (FC2, IC2, NC2 and OC2) and clones expressing the empty vector (4C2 and 7C2) as controls. The level of OMgp overexpression achieved was 2 ± 10-fold, as assessed by Western blotting. Two of the clones overexpressing OMgp are shown in Figure 1a and b. For convenience, NIH3T3 clones overexpressing OMgp are referred to as OM+ in the remainder of this paper.
The OMgp gene lies within an intron of the NF1 gene on the opposite strand and could thus in¯uence the expression of the NF1 gene. In order to examine this possibility, we studied the eect of OMgp transfection on the expression of neuro®bromin, but found no dierence in the levels of neuro®bromin or neuro®bromin message in cells transfected with OMgp in either a sense or an antisense orientation (Figure 1c ).
Tyrosine phosphorylation of the PDGF receptor, its kinase activity, and ERK activation is intact in OM+ cells A crucial early event in PDGF signaling is tyrosine phosphorylation of intracellular proteins (Frackleton et al., 1984) . In this study we have examined signaling through the PDGFb receptor. We studied the eect of OMgp overexpression on PDGF induced tyrosine phosphorylation in whole cell lysates of NIH3T3 ®broblasts and found no attenuation of the general pattern of tyrosine phosphorylation of proteins in OM+ (not shown). Tyrosine phosphorylation of the PDGFb receptor in response to PDGF is intact. This was assessed by immunoprecipitating the PDGFb receptor from cells with and without PDGF stimulation, using receptor speci®c antibodies and immunoblotting with phosphotyrosine antibodies. This experiment was also performed using phosphotyrosine antibodies to immunoprecipitate and immunoblotting with PDGFbR antibodies. The tyrosine phosphorylation of PLCg1 in response to PDGF is also intact in these cells (data not shown). Thus, OMgp does not seem to in¯uence either PDGFR dimerization or the kinase activity of the receptor.
To study the in¯uence of OMgp expression on Ras signaling in NIH3T3 ®broblasts we tested various cell lines for activation of MAP kinases (ERKs) in response to PDGF using an antibody that recognizes the active form of the kinases. OMgp expression does not in¯uence activation of ERKs in response to PDGF (not shown). This suggests that Ras signaling is, at least in part, intact in these cells.
Activation of c-Src
Activation of the PDGF receptor results in the creation of binding sites for the SH2 domains of the Src family members Src, Fyn and Yes. This interaction results in a small but consistent increase in the kinase activities of these proteins in NIH3T3 ®broblasts (Kypta et al., 1990; Gould and Hunter, 1988) . We measured the activation of c-Src in response to PDGF in NIH3T3 cell lines following 24 h of serum starvation. In wild type cells and control transfectants we observed the predicted increase in kinase activity in response to PDGF. In OM+, however, Src kinase activity 
Induction of immediate early genes
The signaling cascade initiated by an activated growth factor receptor culminates in the transcription of a number of genes that are important for the biological eects of growth factors. These include the immediate early genes, which have an important role in mitogenesis of ®broblasts (Kovary and Bravo, 1991; Barone and Courtneidge, 1995) . We studied the eects of OMgp overexpression on the induction of the immediately early genes c-fos, c-myc, and c-jun. Stimulation of serum starved cells with PDGF for 30 min results in an increase in c-Fos expression in untransfected NIH3T3 ®broblasts as well as in the control transfectants (Figure 3a) . In sharp contrast, PDGF induced expression of c-Fos is abolished in OM+. Similarly, the induction of c-Myc, which peaks later, is also highly attenuated ( Figure 3b ). Growth factor mediated induction of c-Fos is believed to result from activation of Ras ± Raf ± MEK ± ERK pathway, whereas c-Jun may be regulated dierently, with posttranslational amino terminal phosphorylation and induction resulting from activation of the JNK ± SAPK pathway (Karin and Hunter, 1995) . In contrast to the lack of c-Fos and c-Myc induction in OM+, the induction of c-Jun in response to PDGF is robust and similar to that seen in controls (Figure 3c ).
Eects on growth and cell cycle analysis
Overexpression of OMgp has profound eects on the growth of NIH3T3 ®broblast. The cells grow slowly in 10% serum, taking twice as long as the controls to reach culture con¯uence. They are more responsive to contact inhibition than untransfected cells and control transfectants and reach culture con¯uence at a lower cell density (data not shown). We measured the number of viable cells in OM+ and in control cultures grown in 10% FBS, using the MTT conversion assay. While the growth of cells overexpressing OMgp is markedly slowed compared to controls (Figure 4 ) OMgp overexpression does not in¯uence cell viability. This was tested by trypan blue exclusion. After 48 h of serum starvation 495% of cells expressing OMgp remained viable which is similar to what is seen with controls (not shown). Thus OMgp mediated growth suppression results from a block of mitogenic signaling rather than an activation of cell death pathways.
We next studied the eect of constitutive OMgp overexpression on the distribution of cells in the cell cycle in NIH3T3 ®broblasts. Cell populations overexpressing OMgp showed an increased number of cells in G 0 -G 1 phase and a decreased number of cells in S-phase compared to controls, as can be seen in Figure  5 . This is consistent with a downregulation of mitogenic signaling since such signals in¯uence the G 1 phase of the cell cycle (Sherr, 1994) .
Next we examined the in¯uence of OMgp on the ability of NIH3T3 ®broblasts to initiate DNA synthesis in response to PDGF. PDGF ± BB has been shown to stimulate DNA synthesis in these cells (Fleming et al., 
1989
). 5610 3 cells were plated in 96 well microtiter plates. After 48 h of serum starvation, PDGF ± BB was added for 18 h and a BrdU incorporation assay was used to measure DNA synthesis. In untransfected ®broblasts and control transfectants an increase in BrdU incorporation compared to unstimulated cells can be detected whereas there was no increase in BrdU incorporation in any OM+ clone in response to PDGF (Figure 6 ).
Discussion
Eects on growth
Overexpression of OMgp in NIH3T3 ®broblasts has growth suppressive eects. Our data suggests that OMgp mediated growth suppression is the result of inhibition of PDGF induced mitogenesis rather than activating cell death pathways. This is likely to result from a blockade of the Src-Myc mitogenic signaling cascade since PDGF induced mitogenesis in NIH3T3 ®broblasts is Src dependent, and we have demonstrated that PDGF induced activation of Src kinase activity and Myc induction are blocked in cells overexpressing OMgp.
Negative regulation of the Ras signaling cascade is mediated through GTPase activating proteins which in mammals include p120 GAP and neuro®bromin. These proteins accelerate the intrinsic GTPase activity of p21 ras and thus favor the inactive GDP bound state. OMgp is encoded by a gene that is embedded in the neuro®bromin encoding NF1 gene. Overexpression of neuro®bromin in NIH3T3 ®broblasts has a growth suppressive eect and can reverse v-ras but not v-raf mediated transformation, although this eect apparently does not result from increased GTP hydrolysis of p21 ras (Johnson et al., 1994) . As noted in the discussion earlier studies had suggested an in¯uence of Src signaling on the Ras pathway. Thus, the two proteins in¯uence mitogenic signaling pathways that are closely related. Furthermore, a comparison of our results with a previous study (Johnson et al., 1994) of neurofi- Figure 5 Cell cycle analysis. 10 5 cells were plated in 100 mm dishes. After 2 days cells were trypsinized, ®xed and stained with propidium iodide and subjected to FACS analysis. In cells populations overexpressing OMgp (ZZ and EC) a greater percentage of cells are found in G 0 /G 1 compared to controls, suggesting a partial block. This experiment is representative of three dierent experiments. Clone CC gave a similar result. The panel marked control shows an antisense clone (FC2) Figure 6 PDGF stimulation of serum starved cells, (see Materials and methods) leads to a small but consistent increase in BrdU incorporation in untransfected NIH3T3 cells and control transfectants (C is clone FC2, antisense) whereas OMgp overexpressors, marked (+), do not show this increase. Data shown represent the ratio of BrdU incorporated in cells with and without PDGF. Each experiment was done in triplicate and the data shown here represent the average of three independent experiments. Error bars show 95% con®dence limits. Dierences in the mean values between OMgp expressing clones and controls in response to PDGF were also examined using a Student t-test. A statistically signi®cant dierence was noted for BrdU incorporation in all OMgp clones compared to controls (P50.05) bromin overexpression in NIH3T3 ®broblasts, suggests that, under similar experimental conditions, the growth suppressive eects of OMgp may be more powerful.
OMgp suppresses activation of c-Src; a possible mechanism of action How OMgp, con®ned to the outer lea¯et of the membrane bilayer and integrated into the membrane only by phosphatidyl inositol, in¯uences intracellular signaling events remains to be elucidated. Our initial attempts at co-immunoprecipitating OMgp with the PDGFb receptor have failed. Since tyrosine phoshorylation of the PDGFb receptor is intact, the site of action is probably downstream of autophosphorylation of the receptor and upstream of c-Src, the activation of which is blocked.
A clue to the mechanism of OMgp action maybe found in the known association between GPI linked proteins and the Src-family tyrosine kinases, although the basis of this association remains unclear (Brown, 1993) . Antibody mediated cross linking of certain GPI linked proteins leads to tyrosine phosphorylation (Hsi et al., 1989) , coimmunoprecipitation of active kinases belonging to the Src family (Stefanova et al., 1991; Thomas and Samelson, 1992) , and functional responses, such as IL-2 production (Shenoy-Scaria et al., 1992). Antibody mediated cross linking of OMgp does not lead to tyrosine phosphorylation of intracellular proteins and we have been unable to coimmunoprecipitate Src, Fyn or Yes with OMgp. Overexpression of OMgp does, however, completely block PDGF induced activation of c-Src. Indeed in OM+ PDGF has the opposite eect of decreasing cSrc activity below basal levels. Thus, the mechanism of action of OMgp in altering PDGF signal transduction may be, in part, the suppression of c-Src activation. Thus, although previous work has demonstrated that GPI linked proteins may activate Src family kinases (Brown, 1993; Hall et al., 1994) we believe this is the ®rst report of a GPI linked protein having the eect of suppressing growth factor induced activation of c-Src. One possibility is that OMgp overexpression leads to sequestration of Src at the cell membrane, making it unavailable to its upstream target. As noted in the introduction activation of Src family members is required for PDGF induced mitogenesis in fibroblasts. Src family members may have both Ras dependent and Ras independent eects on mitogenic signaling, which may explain the block of Fos induction in OMgp over-expressing cells.
It should also be noted that glypicans, which are a family of cell surface proteoglycans anchored to the cell surface through glycosylphosphatidylinositol (GPI) linkage are known to modulate cellular responses to growth factors (Weksberg et al., 1996) .
A gene within a gene
The OMgp gene is within an intron of the NF1 gene and it is transcribed from the strand opposite to the one used for the NF1 transcription. This is an unusual (Viskochil et al., 1991) and complicated arrangement and we suggest that there may be a gain from it, such that it could be viewed as an evolutionary rationale for maintaining this complexity.
One possible gain from this arrangement is reciprocity in the control of expression through sense/ antisense mechanisms. The primary transcript of the NF1 gene could inhibit the conversion of the OMgp transcript into OMgp. The OMgp transcript could interfere with splicing of the NF1 transcript and in that the expression of the gene (Khochbin and Lawrence, 1989) . Since the distributions of OMgp and neurofibromin are very similar (Habib et al., submitted), this seems unlikely. Furthermore, overexpression of OMgp in NIH3T3 ®broblasts does not in¯uence the expression of neuro®bromin. Another gain may be found in relationships between the functions of the two gene products. The results described here show that OMgp, like neuro®bromin, serves to inhibit proliferation of NIH3T3 ®broblasts. Therefore, not only is the OMgp gene within the NF1 gene and the two genes are expressed in the same cell types but, at least in one system, the products of the genes serve a similar function, which is to diminish cell proliferation, and they do it by in¯uencing related pathways. It is possible that the combined action of the two may provide a more eective downregulation than each does separately. Although the eects of OMgp expression in ®broblasts may not be the same as in neurons or myelin producing cells, these observations suggest that OMgp and neuro®bromin may exercise related functions in the nervous system as well. How this relationship in function makes it advantageous to place one of the genes within the other is yet to be determined.
Neuro®bromatosis type 1 is an autosomal dominant disease aecting approximately one in 3500 individuals around the world (Riccardi, 1981) . The abnormalities found in the disease are remarkably diverse including dermal ®bromas, plexiform neuro®bromas, hyperpigmentation of skin, bone lesions, cerebral heterotopias and blood vessel abnormalities. Although mutations in the NF1 gene have been identi®ed in 20% of patients, a number of questions about the pathogenesis of the disease remain unanswered. For example, the pathogenesis of the neuro®broma is not explained by current theories of neuro®bromin function (Ridley et al., 1988; Kim et al., 1995) ; also, there is no explanation to the wide variation in the expressivity of the disease, observed even among family members carrying the same mutation in NF1. This has led to the hypothesis (McCormick, 1995) that mutations in genes other than NF1 may be necessary for development of the full phenotype. We are currently investigating if interference with the proper function of the OMgp gene may be one step in a multi-step pathogenesis of NF1 lesions (Vogelstein and Kinzler, 1993) .
Materials and methods
Cell lines, construction of recombinant plasmids and transfections
The entire coding sequence of the mouse OMgp gene was used (Mikol et al., 1993) . First a 1165 bp PstI fragment was isolated from P4-2, a mouse genomic DNA clone, and placed into Blusescript. Next, a 176 base pair fragment was generated using PCR incorporating a Kozak consensus sequence GCCGCCACC to increase the eciency of translation. This fragment was ligated and cloned into the Bluescript vector containing the ®rst fragment, which thus was equipped with the entire coding region, in addition to the incorporated Kozak sequence. This was excised from Bluescript and cloned into the PCDNA1/Neo vector (Invitrogen) in both a sense and an antisense orientation, using standard molecular techniques (Ausubel et al., 1991) . Orientation of the constructs was con®rmed by sequencing.
NIH3T3 ®broblasts were obtained from ATCC and maintained in modi®ed DMEM supplemented with 10% FBS. Transfections were done using Lipofectamine (GIBCO-BRL) according to the manufacturer's protocol. G418 selection was used at a concentration of 500 mg/ml and individual clones were expanded into stable cell lines that were analysed with Southern blotting. Five independent clones showed stable integration of the OMgp gene. Four of these clones (CC, EC, LC, and ZZ) were further analysed by Northern and Western blotting, found to overexpress OMgp, and were used in the experiments described. The level of overexpression achieved was 2 ± 10-fold as assessed by Western blotting. For convenience, NIH3T3 clones overexpressing OMgp are referred to as OM+ in this paper. We have detected OMgp mRNA in NIH3T3 cells using RT ± PCR, and have also observed a small amount of protein on Western blots. As controls (termed control transfectants) we used four independent clones with the OMgp construct in an antisense orientation named FC2, IC2, NC2 and OC2, and two clones transfected with the vector alone named 4PC and 7PC.
Western blotting, immunoprecipitation and antibodies
For studies of protein tyrosine phosphorylation cell lines were serum starved for 24 h, then exposed to PDGF ± BB, (GIBCO BRL) 50 ng/ml, for 5 min, lysed in SDS sample buer and equal amounts were subjected to SDS ± PAGE and transferred to nitrocellulose sheets. Protein quantitation was performed using a Bio-Rad Protein Assay kit, and by Coumassie staining of aliquots. Mouse monoclonal antiphosphotyrosine antibody, clone 4G10 (Upstate Biotech, NY), was used and Western blots were visualized with ECL detection reagents (Amersham). Immunoprecipitation was performed using standard protocols (Ausubel et al., 1991) . For studies of phosphorylation of the PDGFb receptor, cell lines were serum deprived for 24 h, exposed to PDGF ± BB (50 ng/ml) for 5 min and lysed in RIPA buer (150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50 mM Tris) containing 2 mM sodium orthovanadate and 1 mM PMSF. The lysate was centrifuged and the supernatant was incubated for 2 h with a PDGFb receptor antibody. Protein A Sepharose beads were subsequently added for 1 h. The beads were washed four times in lysis buer, resuspended in SDS sample buer and analysed with SDS ± PAGE, followed by Western blotting and staining with phosphotyrosine antibodies. The blots were stripped and reprobed with PDGFb receptor antibodies. Alternatively, immunoprecipitation was performed using phosphotyrosine antibodies and immunoblotting was done with PDGFb receptor antibodies.
Studies of PLCg1 tyrosine phosphorylation were carried out in an identical fashion using PLCg1 antibodies. Studies of co-immunoprecipitation of the PDGFb receptor with OMgp were done by immunoprecipitating the PDGFb receptor as above and probing Western blots with OMgp antibodies. A similar experiment was done using Src, Fyn, and Yes antibodies. Neuro®bromin levels were analysed in whole cell lysates from various clones by Western blotting and probing with rabbit polyclonal neuro®bromin antiserum, a kind gift of Drs M Golubic and D Stacey (Cleveland Clinic, Ohio). Rabbit polyclonal antibodies raised against OMgp in our laboratory (Mikol and StefaÂ nsson, 1990 ) were used to analyse OMgp levels. Cross-linking studies were done by incubating cell lines with OMgp speci®c antibodies or normal rabbit serum for 10 min, followed by Western blot analysis using phosphotyrosine antibodies. Antibodies to the PDGFb receptor, PLCg1, ERK2, Src, Fyn and Yes, were purchased from Santa Cruz Biotechnology, CA. An anti-active MAPK antibody which recognizes the dually phosphorylated form of the ERKs was obtained from Promega, Madison, Wisconsin (Cat No. V6671), and used in Western blots to assess ERK activation in response to PDGF.
Immune complex kinase assays
Cell lines were serum starved for 24 h and PDGF ± BB (50 ng/ml) was added for 10 min. Following this immunoprecipitation with a c-Src antibody was performed as described above. A Src Kinase Assay Kit (Upstate Biotech, New York) utilizing a synthetic peptide derived from p34 cdc2 , (EKIGEGTYGVKKK) was used according to the manufacturers instructions. This peptide has previously been demonstrated to be a speci®c substrate for c-Src (Cheng et al., 1992) . Incorporation of phosphorylated peptide into P81 phosphocellulose paper was measured by scintillation counting. Three independent experiments were done.
Northern blots
Cells were serum starved for 24 h for studies of gene induction. For studies of c-Fos and c-Jun induction cells were incubated with PDGF ± BB (50 ng/ml) for 30 min. cMyc induction was studied at 30 min and at 2 h 45 min of PDGF exposure. Northern blots were performed according to standard protocols. The c-Fos probe was a 250 bp fragment derived from exon 2 of the mouse gene, and the c-Myc probe was a 329 bp fragment derived from exon 3 of the mouse gene. The c-Jun probe was a 205 bp fragment of the c-jun gene. All templates were purchased from Ambion, Texas. Probes were labeled with a 32 P-dCTP (NEN) using random priming. For detection of OMgp message 4 mg of poly(A) + RNA were analysed. OMgp sense and antisense probes were generated with arithmetic PCR using a single primer in the reaction (Agarwal and White, 1993) . The OMgp construct used for transfection was used as a template. Primer MG22, 5'-AGAGACC-GAGGTAACTGAGCAGGC and primer MG8 5'-AAT-GACCAATTCCCATGAAGCAGC, were used in the PCR reaction to detect sense and antisense message, respectively. The probe synthesized in each case was about 300 bp in size. Equal loading of RNA was determined by probing for 18S ribosomal RNA or GAPDH.
Cell survival and proliferation assay
Wild type NIH3T3 cells, OM+ and control transfectants were plated at a density of 3610 3 cells in 24 well tissue culture dishes in 10% FBS. Cell proliferation was assessed using 3-(4,5-dimethylthiazol 2-4L)-2,5-diphenyltetrazolin bromide (MTT). MTT was added at a concentration of 0.5 mg/ml at 4 and 72 h after plating the cells, and incubated at 378C for 3 h. At the end of the incubation period the converted dye was solubilized with acidic isopropanol and the absorbance was measured at a wavelength of 570 nm. Three independent experiments were done in triplicate.
The ability of PDGF to induce DNA synthesis was assessed with a BrdU incorporation assay. Brie¯y 5610 3 cells were plated in 96 well microtiter plates in 10% FBS. The next day medium was aspirated and the cells were incubated in a serum free medium supplemented with insulin 10 mg/ml, transferrin 5.5 mg/ml and trace amounts of selenium for a further 48 h. Following this BrdU (5 mM) and PDGF ± BB (30 ng/ml) were added for 18 h. BrdU incorporation was measured with an ELISA using a published protocol (Muir et al., 1990) . All experiments were done in triplicates and three independent experiments were done. Dierences in the mean values between the groups were examined using Student's ttest, and P values 50.05 were considered statistically signi®cant.
Cell cycle analysis
Cells were plated at 5610 5 cells per 100 mm dish in DMEM with 10% FBS. Two days later the cells were trypsinized, ®xed and stained with propidium iodide. 10 6 cells were subjected to FACS analysis, using SellQuest (Becton Dickinson) for cell acquisition and ModFit LT (Verity) for statistical analysis.
